Under the first and second phase of the Horizontal Facility, support was provided to assist the Beneficiaries in bringing their policies, institutions and practices further in line with the ...

Background Fibrolamellar carcinoma (FLC), a rare and fatal liver cancer lacking effective drug therapy, is driven by the DNAJ ...